BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12655568)

  • 41. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
    Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
    Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer.
    Viel A; Genuardi M; Capozzi E; Leonardi F; Bellacosa A; Paravatou-Petsotas M; Pomponi MG; Fornasarig M; Percesepe A; Roncucci L; Tamassia MG; Benatti P; Ponz de Leon M; Valenti A; Covino M; Anti M; Foletto M; Boiocchi M; Neri G
    Genes Chromosomes Cancer; 1997 Jan; 18(1):8-18. PubMed ID: 8993976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mutation analysis of hMSH2 and hMLH1 genes in Chinese hereditary nonpolyposis colorectal cancer families].
    Cai Q; Sun MH; Fu G; Ding CW; Mo SJ; Cai SJ; Ren SX; Min DL; Xu XL; Zhu WP; Zhang TM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):323-8. PubMed ID: 14514376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer.
    Genuardi M; Anti M; Capozzi E; Leonardi F; Fornasarig M; Novella E; Bellacosa A; Valenti A; Gasbarrini GB; Roncucci L; Benatti P; Percesepe A; Ponz de Leòn M; Coco C; de Paoli A; Valentini M; Boiocchi M; Neri G; Viel A
    Int J Cancer; 1998 Mar; 75(6):835-9. PubMed ID: 9506527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
    Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Online.
    Holmberg M; Kristo P; Chadwicks RB; Mecklin JP; Järvinen H; de la Chapelle A; Nyström-Lahti M; Peltomäki P
    Hum Mutat; 1998; 11(6):482. PubMed ID: 10200055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families.
    Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR
    World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
    Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
    Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
    Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
    Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
    Alazzouzi H; Domingo E; González S; Blanco I; Armengol M; Espín E; Plaja A; Schwartz S; Capella G; Schwartz S
    Hum Mol Genet; 2005 Jan; 14(2):235-9. PubMed ID: 15563510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations.
    Peltomäki P; Gao X; Mecklin JP
    Fam Cancer; 2001; 1(1):9-15. PubMed ID: 14574010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic analysis of microsatellite markers in patients from hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Smolarz B; Romanowicz-Makowska H; Langner E; Kozlowska E; Kulig A; Dziki A
    Exp Oncol; 2004 Sep; 26(3):205-9. PubMed ID: 15494688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
    Renkonen E; Zhang Y; Lohi H; Salovaara R; Abdel-Rahman WM; Nilbert M; Aittomaki K; Jarvinen HJ; Mecklin JP; Lindblom A; Peltomaki P
    J Clin Oncol; 2003 Oct; 21(19):3629-37. PubMed ID: 14512394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A proven de novo germline mutation in HNPCC.
    Kraus C; Kastl S; Günther K; Klessinger S; Hohenberger W; Ballhausen WG
    J Med Genet; 1999 Dec; 36(12):919-21. PubMed ID: 10594000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.
    Millar AL; Pal T; Madlensky L; Sherman C; Temple L; Mitri A; Cheng H; Marcus V; Gallinger S; Redston M; Bapat B; Narod S
    Hum Mol Genet; 1999 May; 8(5):823-9. PubMed ID: 10196371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
    Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
    Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations predisposing to hereditary nonpolyposis colorectal cancer.
    Peltomäki P; de la Chapelle A
    Adv Cancer Res; 1997; 71():93-119. PubMed ID: 9111864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.